UHT

Business Context and Reporting Period

Company: Universal Health Realty Income Trust
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2000
Business Overview: The Trust invests in healthcare and human service-related facilities, including hospitals, surgery centers, and medical office buildings across 14 states. Approximately 64% of consolidated revenues are derived from leases with subsidiaries of Universal Health Services, Inc. (UHS), which also serves as the Trust's Advisor and owns approximately 8% of the Trust's shares.

Key Financial Metrics

Material Changes vs. Prior Period

• Revenue Growth: Total revenues increased by $629,000 (10.4%) primarily due to a $783,000 increase in base rental revenue from non-related parties. This was partially offset by a $234,000 decrease in interest income as short-term loans to LLCs were repaid.
• Expense Increases: Interest expense rose 39% ($397,000) due to increased borrowings for new investments. Depreciation and amortization increased 15% ($141,000) due to new acquisitions. Other operating expenses increased 33% ($177,000), largely driven by expenses from newly acquired medical office buildings.
• Net Income: Despite higher revenues, net income remained flat ($3,916,000 vs. $3,928,000) due to the offsetting increases in interest and operating expenses.
• Acquisitions: The Trust invested $6.4 million in a medical office building in Danbury, Connecticut, and $1.8 million for a 95% equity interest in an LLC owning a facility in Torrance, California.

Guidance, Outlook, and Risks

• Liquidity: The Trust maintains approximately $17 million of unused borrowing capacity under a $100 million revolving credit agreement expiring in June 2003.
• Capital Allocation: A stock repurchase program was approved for up to 500,000 shares; 9,100 shares were repurchased in Q1 2000. A quarterly dividend of $0.455 per share was declared and paid.
• Accounting Changes: The Trust must adopt SFAS No. 133 (Derivatives and Hedging) effective January 1, 2001. Management has not yet quantified the impact but notes it could increase earnings volatility.
• Risks: Significant reliance on UHS (64% of revenue); exposure to healthcare industry changes, including reimbursement levels from Medicare/Medicaid; and the ability to finance growth on favorable terms.

Investor Verification Checklist

• Verify the concentration risk associated with UHS, which accounts for 64% of revenues and serves as the Advisor.
• Confirm the impact of the upcoming SFAS No. 133 adoption on future earnings volatility.
• Review the utilization of the $100 million credit facility and the terms of the $84.3 million outstanding bank borrowings.
• Assess the performance of recent acquisitions (Danbury, CT and Torrance, CA) in subsequent quarters.
• Monitor the sustainability of the dividend payout ratio given the flat net income and increased interest expenses.